Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer.

Lesseur C, Diergaarde B, Olshan AF, Wünsch-Filho V, Ness AR, Liu G, Lacko M, Eluf-Neto J, Franceschi S, Lagiou P, Macfarlane GJ, Richiardi L, Boccia S, Polesel J, Kjaerheim K, Zaridze D, Johansson M, Menezes AM, Curado MP, Robinson M, Ahrens W, Canova C, Znaor A, Castellsagué X, Conway DI, Holcátová I, Mates D, Vilensky M, Healy CM, Szeszenia-Dąbrowska N, Fabiánová E, Lissowska J, Grandis JR, Weissler MC, Tajara EH, Nunes FD, de Carvalho MB, Thomas S, Hung RJ, Peters WH, Herrero R, Cadoni G, Bueno-de-Mesquita HB, Steffen A, Agudo A, Shangina O, Xiao X, Gaborieau V, Chabrier A, Anantharaman D, Boffetta P, Amos CI, McKay JD, Brennan P.

Nat Genet. 2016 Dec;48(12):1544-1550. doi: 10.1038/ng.3685. Epub 2016 Oct 17.

2.

A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity.

Chen D, Gaborieau V, Zhao Y, Chabrier A, Wang H, Waterboer T, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Bencko V, Janout V, Foretova L, Mates IN, Szeszenia-Dabrowska N, Boffetta P, Pawlita M, Lathrop M, Gyllensten U, Brennan P, McKay JD.

Hum Mol Genet. 2015 May 1;24(9):2681-8. doi: 10.1093/hmg/ddv015. Epub 2015 Jan 23.

PMID:
25616963
3.
4.

Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.

Hu JM, Sun Q, Li L, Liu CX, Chen YZ, Zou H, Pang LJ, Zhao J, Yang L, Cao YW, Cui XB, Qi Y, Liang WH, Zhang WJ, Li F.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6165-71. eCollection 2014.

5.

Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.

Kohaar I, Hussain S, Thakur N, Tiwari P, Nasare V, Batra S, Singh V, Bhambani S, Das BC, Sarkar DP, Bharadwaj M.

Hum Immunol. 2009 Apr;70(4):222-9. doi: 10.1016/j.humimm.2009.01.003. Epub 2009 Jan 18.

PMID:
19272325
6.

Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype.

Arias-Pulido H, Joste N, Wheeler CM.

Genes Chromosomes Cancer. 2004 Aug;40(4):277-84.

PMID:
15188450
7.

Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.

Gokhale P, Kerkar S, Tongaonkar H, Chaudhari H, Warke H, Salvi V, Mania-Pramanik J.

Indian J Med Res. 2014 Nov;140 Suppl:S36-43.

8.

Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women.

Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1183-91.

9.

Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri.

Beskow AH, Gyllensten UB.

Int J Cancer. 2002 Oct 20;101(6):526-31.

10.

Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus.

Chen D, Enroth S, Liu H, Sun Y, Wang H, Yu M, Deng L, Xu S, Gyllensten U.

Oncotarget. 2016 Jul 5;7(27):42216-42224. doi: 10.18632/oncotarget.9916.

11.

Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles.

Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS.

Int J Cancer. 1996 Sep 4;67(5):595-602.

12.

Genome-wide association study of susceptibility loci for cervical cancer.

Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, Gustavsson I, Feuk L, Magnusson PK, McKay JD, Wilander E, Gyllensten U.

J Natl Cancer Inst. 2013 May 1;105(9):624-33. doi: 10.1093/jnci/djt051. Epub 2013 Mar 12.

PMID:
23482656
13.

Human leukocyte antigen class II alleles and natural history of HPV 2/27/57-induced common warts.

Spelten B, Grussendorf-Conen EI, Rübben A.

Arch Dermatol Res. 2004 Aug;296(3):105-11. Epub 2004 Jul 15.

PMID:
15257408
14.

HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.

Trachtenberg E, Vinson M, Hayes E, Hsu YM, Houtchens K, Erlich H, Klitz W, Hsia Y, Hollenbach J.

Tissue Antigens. 2007 Dec;70(6):455-63. Epub 2007 Sep 27.

PMID:
17900288
15.

Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosis.

Rubio JP, Bahlo M, Butzkueven H, van Der Mei IA, Sale MM, Dickinson JL, Groom P, Johnson LJ, Simmons RD, Tait B, Varney M, Taylor B, Dwyer T, Williamson R, Gough NM, Kilpatrick TJ, Speed TP, Foote SJ.

Am J Hum Genet. 2002 May;70(5):1125-37. Epub 2002 Mar 29.

16.

Human leukocyte antigen class II and cervical cancer risk: a population-based study.

Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, Nelson JL, Porter P, Shera KA, McDougall JK, Galloway DA.

J Infect Dis. 2002 Dec 1;186(11):1565-74. Epub 2002 Nov 4.

PMID:
12447731
17.

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.

Hor H, Kutalik Z, Dauvilliers Y, Valsesia A, Lammers GJ, Donjacour CE, Iranzo A, Santamaria J, Peraita Adrados R, Vicario JL, Overeem S, Arnulf I, Theodorou I, Jennum P, Knudsen S, Bassetti C, Mathis J, Lecendreux M, Mayer G, Geisler P, Benetó A, Petit B, Pfister C, Bürki JV, Didelot G, Billiard M, Ercilla G, Verduijn W, Claas FH, Vollenweider P, Waeber G, Waterworth DM, Mooser V, Heinzer R, Beckmann JS, Bergmann S, Tafti M.

Nat Genet. 2010 Sep;42(9):786-9. doi: 10.1038/ng.647. Epub 2010 Aug 15. Erratum in: Nat Genet. 2011 Apr;43(4):388. Vollenwider, Peter [corrected to Vollenweider, Peter].

PMID:
20711174
18.

Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.

Chan PK, Cheung TH, Lin CK, Siu SS, Yim SF, Lo KW, Cheung JL, Tam AO, Tang JW.

J Med Virol. 2007 Jul;79(7):970-6.

PMID:
17516530
19.

Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.

Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1035-41.

20.

Human papillomavirus and risk of oral cancer.

Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH.

Laryngoscope. 1998 Jul;108(7):1098-103.

PMID:
9665264

Supplemental Content

Support Center